Intuitive’s da Vinci: Will Familiarity Breed Success?
Robotic soft-tissue MIS pioneer Intuitive Surgical continues to advance its offering in this disruptive area of medical technology. Having weathered an adverse incident-related storm, it is putting efforts into driving OUS business, broadening surgical applications, and convincing the doubters about robotic surgery’s place and role in the catalog of care delivery.
You may also be interested in...
Medtech advancements leading to cost savings and improved outcomes are the result of a confluence of three elements: technology, clinical processes, and the business case, according to consultant thoracic surgeon Aman Coonar.
Robot-assisted surgery for kidney cancers improves outcomes by allowing partial nephrectomies, reducing mortalities and lowering some health care costs said economist Julia Thornton Snider at a Feb. 5 biomedical innovation meeting, but researchers did not compare robotic surgeries with laparoscopic or open surgeries, nor did they examine costs of deaths or other bad patient outcomes linked to robotic surgeries.
The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.